Acadia Pharmaceuticals | ACAD - Trade Creditors


Acadia Pharmaceuticals reported $21.75M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
ALKERMES USD 68M 31.21M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Biogen USD 413.1M 4.7M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Corcept Therapeutics USD 34.45M 10.92M Sep/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
Eisai JPY 80.73B 2.26B Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Incyte USD 171.92M 1.24B Sep/2025
J&J USD 9.62B 161M Sep/2025
Moderna USD 267M 92M Sep/2025
Neurocrine Biosciences USD 119.9M 15.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Prothena USD 10.5M 1.7M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025